⏱ News is delayed by 15 minutes. Sign in for real-time access.
Sign in
DTIL News
Precision BioSciences, Inc. Common Stock
Precision BioSciences Activates First Clinical Trial Site and Begins Patient Enrollment in Phase 1/2 FUNCTION-DMD Study
businesswire.com
DTIL
iECURE to Present Preliminary Clinical Data from Ongoing OTC-HOPE Trial of ECUR-506 in Neonatal-Onset Ornithine Transcarbamylase Deficiency at the ASGCT and SIMD Annual Meetings
businesswire.com
DTIL
Precision BioSciences Announces Oral Presentation at the American Society of Gene and Cell Therapy (ASGCT) 2026 Annual Meeting
businesswire.com
DTIL
Precision BioSciences Announces Grant of Inducement Awards Under Nasdaq Listing Rule 5635(c)(4)
businesswire.com
DTIL
Precision BioSciences to Participate in the 25th Annual Needham Virtual Healthcare Conference
businesswire.com
DTIL
Delinea Appoints Scott Goree as SVP of Channel and Alliances to Lead Next Phase of Partner-Led Growth
globenewswire.com
DTIL
NTNX
PSTG
CSCO
The Inner Circle acknowledges Gahn Lane, MBA as a Pinnacle Professional Member Inner Circle of Excellence
prnewswire.com
DTIL
Form 8-K
sec.gov
DTIL
Form 8-K
sec.gov
DTIL
Precision BioSciences Receives U.S. Patent Allowances Covering the PBGENE-HBV Program
businesswire.com
DTIL